CVE-2023-33861

CVE-2023-33861 is a medium-severity vulnerability in Ibm Security Qradar Edr with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-295.

Key facts

Description

IBM Security ReaQta EDR 3.12 could allow an attacker to spoof a trusted entity by interfering with the communication path between the host and client.

Frequently asked questions

What is CVE-2023-33861?
IBM Security ReaQta EDR 3.12 could allow an attacker to spoof a trusted entity by interfering with the communication path between the host and client.
How severe is CVE-2023-33861?
CVE-2023-33861 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2023-33861 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-33861?
CVE-2023-33861 affects Ibm Security Qradar Edr. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-33861?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-33861 have an EU (EUVD) identifier?
Yes. CVE-2023-33861 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-38011.
When was CVE-2023-33861 published?
CVE-2023-33861 was published on 2025-05-20 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Security Qradar Edr

All CVEs affecting Ibm Security Qradar Edr →

Other CWE-295 (Improper Certificate Validation) vulnerabilities

Browse all CWE-295 (Improper Certificate Validation) vulnerabilities →